vivo assessment antimicrobial agents Toxoplasma gondii quantification parasites blood lungs brain infected mice vivo effects antimicrobial agents Toxoplasma gondii mice tachyzoites RH strain determination survival rates study kinetics growth gondii infected mice various intervals infection subcultures serial dilutions blood lung brain homogenates fibroblast tissue cultures determination parasitic loads Pyrimethamine mg/kg day sulfadiazine mg/kg day clindamycin mg/kg day days day day infection control mice days early predominant lung involvement mice sulfadiazine day healthy parasitic loads treatment relapse days cessation therapy pyrimethamine day mice days determination parasitic loads effect pyrimethamine demonstrable day relapse cessation therapy pyrimethamine sulfadiazine combination mice therapy day parasites undetectable mice day parasites day infection days cessation therapy mice clindamycin day day days parasitemia undetectable 